Eli Lilly Customer Service

User Reviews, Ratings and Comments



Eli Lilly must receive 5 more comments in order to receive a customer service rating.
Add your comments and ratings for Eli Lilly customer service

NEGATIVE Comments

POSITIVE Comments

Issue Resolution

Reachability

Cancellation

Friendliness

Product Knowledge

There are currently not enough comments for Eli Lilly to qualify for a rating. Listings must have at least 5 comments before a rating will be calculated.

  • Eli Lilly

    Customer Service Scoreboard

    • 0.00 Overall Rating
      (out of 200 possible)
    • 0 negative comments (0.00%)
    • 0 positive comments (0.00%)
    • 0 employee comments
    • Attribute Ratings
      (out of 10 possible)
    • 0.0 Issue Resolution
    • 0.0 Reachability
    • 0.0 Cancellation
    • 0.0 Friendliness
    • 0.0 Product Knowledge

There are currently 0 Negative Comments for Eli Lilly.

Be the first to submit a negative comment
There are currently 0 Positive Comments for Eli Lilly.

Be the first to submit a positive comment
There are currently 0 Employee Comments for Eli Lilly.

Be the first to submit a comment from an Employee

Awards

We are proud to recognize the companies providing the best customer service each year within their industry.

Comparisons

Check out these popular comparisons of Eli Lilly customer service versus other companies:

Eli Lilly vs. AbbVie
Eli Lilly vs. ADT
Eli Lilly vs. Duke Energy
Eli Lilly vs. Johnson and Johnson
Eli Lilly vs. Merck
Eli Lilly vs. Pfizer
Company Replies

Authorized representatives of Eli Lilly can sign up to reply to any of the comments found on this page.

Sign Up | Sign In

Contact Information
Customer Service
317-276-2000

including steps to reach representatives, hours of operation, customer support links and more from .
Corporate Office

Locate the Eli Lilly corporate office headquarters phone number, address and more at CorporateOfficeOwl.com.

Company News
Eli Lilly (LLY) to Report Q3 Earnings: What's in Store?
Eli Lilly and Company (LLY - Free Report) will report third-quarter 2017 results on Oct 24, before the market opens. Last quarter, the company delivered a positive earnings surprise of 6.73%. Lilly's shares have risen 17% this year so far while the ...
Eli Lilly's Trulicity Benefits From Growth of Diabetes Drugs
"We are benefiting from very significant growth of the GLP-1 class," said Conterno, president of Lilly Diabetes and Lilly USA, at the UBS Global Healthcare Conference in New York. "And in fact, as we see additional competitors, they are further fueling ...
Eli Lilly Sees Modest Revenue Growth in 2018
Eli Lilly and Co. (LLY) said Wednesday it expects a low-single-digit revenue increase next year as it works to cut costs and develop new drugs. The pharmaceutical company is in the "early stages" of a growth period, driven by revenue from recently ...